Seattle, WA, United States of America

Zdenek Spacil

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Zdenek Spacil: Innovator in Lysosomal Storage Disease Research

Introduction

Zdenek Spacil is a notable inventor based in the United States. He has made significant contributions to the field of biochemistry, particularly in the area of lysosomal storage diseases. His work focuses on developing reagents and methods for screening various enzymes associated with these conditions.

Latest Patents

Zdenek Spacil holds a patent titled "Reagents And Methods For Screening Mps I, Ii, Iiia, Iiib, Iva, Vi, And Vii." This invention relates to reagents, methods, and kits designed for assaying enzymes linked to lysosomal storage diseases such as MPS-I, MPS-II, MPS-IIIA, MPS-IIIB, MPS-IVA, MPS-VI, and MPS-VII. The reagents include substrates that feature a carbohydrate moiety and an aglycone moiety, which are essential for the enzymatic assays.

Career Highlights

Throughout his career, Zdenek Spacil has focused on advancing the understanding and treatment of lysosomal storage diseases. His innovative approaches have contributed to the development of effective diagnostic tools that can aid in the early detection of these conditions.

Collaborations

Zdenek has collaborated with esteemed colleagues such as Michael H Gelb and Arun Babu Kumar. These partnerships have enhanced the research and development of his patented methods and reagents.

Conclusion

Zdenek Spacil's work in the field of lysosomal storage diseases exemplifies the importance of innovation in medical research. His contributions continue to pave the way for advancements in diagnostics and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…